Real-world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single-center retrospective study

J Dermatol. 2022 Apr;49(4):469-471. doi: 10.1111/1346-8138.16350. Epub 2022 Mar 6.
No abstract available

Keywords: Japanese; atopic dermatitis; baricitinib; real-world data; retrospective study.

MeSH terms

  • Azetidines* / adverse effects
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Japan
  • Purines
  • Pyrazoles
  • Retrospective Studies
  • Sulfonamides
  • Treatment Outcome

Substances

  • Azetidines
  • Purines
  • Pyrazoles
  • Sulfonamides
  • baricitinib

Grants and funding